Early Postnatal Exposure to Midazolam Causes Lasting Histological and Neurobehavioral Deficits via Activation of the mTOR Pathway

• Published in: International journal of molecular sciences Vol. 25; no. 12; p. 6743
• Main Authors: Xu, Jing, Wen, Jieqiong, Mathena, Reilley Paige, Singh, Shreya, Boppana, Sri Harsha, Yoon, Olivia Insun, Choi, Jun, Li, Qun, Zhang, Pengbo, Mintz, Cyrus David
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.06.2024; MDPI
• Subjects: Anesthesia; Animal cognition; Behavior; Critical care; dendrite morphology; Dexmedetomidine; Hypotheses; Immunohistochemistry; Intensive care; Kinases; long-term effects; Midazolam; mTOR pathway; Neural circuitry; Neurons; Neurotoxicity; Pediatric intensive care; Pediatrics; sedation; Toxicity
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25126743

Exposure to general anesthetics can adversely affect brain development, but there is little study of sedative agents used in intensive care that act via similar pharmacologic mechanisms. Using quantitative immunohistochemistry and neurobehavioral testing and an established protocol for murine sedation, we tested the hypothesis that lengthy, repetitive exposure to midazolam, a commonly used sedative in pediatric intensive care, interferes with neuronal development and subsequent cognitive function via actions on the mechanistic target of rapamycin (mTOR) pathway. We found that mice in the midazolam sedation group exhibited a chronic, significant increase in the expression of mTOR activity pathway markers in comparison to controls. Furthermore, both neurobehavioral outcomes, deficits in Y-maze and fear-conditioning performance, and neuropathologic effects of midazolam sedation exposure, including disrupted dendritic arborization and synaptogenesis, were ameliorated via treatment with rapamycin, a pharmacologic mTOR pathway inhibitor. We conclude that prolonged, repetitive exposure to midazolam sedation interferes with the development of neural circuitry via a pathologic increase in mTOR pathway signaling during brain development that has lasting consequences for both brain structure and function.